Drug
Erbitux
Erbitux: highest development phase Phase 2, developed by Bristol-Myers Squibb. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Bristol-Myers Squibb
Trials
| Drug | Phase | Indication |
|---|---|---|
| Erbitux, Paclitaxel & Carboplatin NCT00343083 | Phase 2 | Cancer of Head and Neck |
Latest
No recent events.
Follow Erbitux on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.